FCI
EW icon

Financial Counselors Inc’s Edwards Lifesciences EW Stock Holding History

Financial Counselors Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,645
Closed -$337K – 192
2025
Q1 		$337K Buy
4,645
+71
+2% +$5.08K 0.01% 477
2024
Q4 		$339K Buy
4,574
+98
+2% +$6.86K ﹤0.01% 473
2024
Q3 		$295K Sell
4,476
-384
-8% -$27.9K ﹤0.01% 511
2024
Q2 		$449K Sell
4,860
-2,142
-31% -$190K 0.01% 422
2024
Q1 		$669K Sell
7,002
-999
-12% -$83.9K 0.01% 375
2023
Q4 		$610K Sell
8,001
-7,602
-49% -$529K 0.01% 373
2023
Q3 		$1.08M Sell
15,603
-56,157
-78% -$4.51M 0.02% 314
2023
Q2 		$6.77M Buy
71,760
+18,816
+36% +$1.64M 0.14% 154
2023
Q1 		$4.38M Sell
52,944
-2,270
-4% -$178K 0.09% 177
2022
Q4 		$4.12M Sell
55,214
-1,824
-3% -$141K 0.09% 185
2022
Q3 		$4.71M Buy
57,038
+2,690
+5% +$259K 0.12% 165
2022
Q2 		$5.17M Buy
54,348
+53
+0.1% +$5.49K 0.12% 163
2022
Q1 		$6.39M Buy
54,295
+1,071
+2% +$120K 0.13% 154
2021
Q4 		$6.89M Buy
53,224
+1,460
+3% +$170K 0.14% 154
2021
Q3 		$5.86M Sell
51,764
-3,409
-6% -$389K 0.13% 168
2021
Q2 		$5.71M Buy
55,173
+3,289
+6% +$310K 0.12% 169
2021
Q1 		$4.34M Buy
51,884
+4,530
+10% +$383K 0.1% 186
2020
Q4 		$4.32M Buy
47,354
+2,017
+4% +$167K 0.11% 180
2020
Q3 		$3.62M Buy
45,337
+3,943
+10% +$308K 0.11% 181
2020
Q2 		$2.86M Buy
41,394
+4,221
+11% +$300K 0.09% 198
2020
Q1 		$2.34M Buy
37,173
+969
+3% +$69.9K 0.1% 180
2019
Q4 		$2.81M Sell
36,204
-366
-1% -$28.6K 0.1% 188
2019
Q3 		$2.68M Sell
36,570
-2,055
-5% -$144K 0.11% 192
2019
Q2 		$2.38M Sell
38,625
-1,758
-4% -$106K 0.1% 200
2019
Q1 		$2.58M Buy
40,383
+669
+2% +$38.2K 0.11% 187
2018
Q4 		$2.03M Buy
39,714
+126
+0.3% +$6.38K 0.1% 195
2018
Q3 		$2.3M Buy
39,588
+957
+2% +$46.8K 0.1% 202
2018
Q2 		$1.88M Buy
38,631
+939
+2% +$43.8K 0.09% 214
2018
Q1 		$1.75M Sell
37,692
-2,415
-6% -$105K 0.08% 219
2017
Q4 		$1.51M Buy
40,107
+2,286
+6% +$83.9K 0.07% 248
2017
Q3 		$1.38M Sell
37,821
-4,176
-10% -$159K 0.07% 251
2017
Q2 		$1.66M Buy
41,997
+1,086
+3% +$39.6K 0.08% 229
2017
Q1 		$1.28M Buy
40,911
+846
+2% +$26.5K 0.07% 253
2016
Q4 		$1.25M Buy
+40,065
New +$1.3M 0.07% 253
2016
Q2 		$1.56M Sell
46,980
-27,570
-37% -$943K 0.09% 211
2016
Q1 		$2.19M Sell
74,550
-36
-0% -$993 0.14% 187
2015
Q4 		$1.96M Buy
74,586
+3,084
+4% +$80.1K 0.13% 188
2015
Q3 		$1.69M Buy
+71,502
New +$1.73M 0.12% 195
2013
Q4 		– Sell
-82,350
Closed -$956K – 412
2013
Q3 		$956K Buy
82,350
+12,972
+19% +$152K 0.08% 231
2013
Q2 		$777K Buy
+69,378
New +$821K 0.06% 235

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Financial Counselors Inc's EW Position: Q2 2025 in Review

Financial Counselors Inc sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 4,645 shares — an estimated $337K sold.

Financial Counselors Inc first reported a position in EW in Q2 2013 and held it in 40 quarters. The position peaked at $6.89M in Q4 2021. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Financial Counselors Inc reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 4,645 Edwards Lifesciences shares in Q2 2025, an estimated $337K.
  • Financial Counselors Inc first reported a position in Edwards Lifesciences in Q2 2013 and held it in 40 quarters.
  • Financial Counselors Inc's Edwards Lifesciences position peaked at $6.89M in Q4 2021.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.